Clinical trial
Molecular and Cellular Mechanism of Vascular Ageing in Chronic Kidney Disease: Role of Theranova Dialyzer on Mineral Metabolism Disorder, Oxidative Stress, and Vascular Calcification
NCT03169400 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular and Cellular Mechanism of Vascular Ageing in Chronic Kidney Disease: Role of Theranova Dialyzer on Mineral Metabolism Disorder, Oxidative Stress, and Vascular Calcification
- Lead sponsor
- University of Milan
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2017
- Completion date
- December 31, 2018
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal failure on dialysis, oxidative stress, vascular calcification